The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Hwang, You Cheol ^a   Jeon, Won Seon ^b   Park, Cheol Young ^b   Youn, Byung Soo ^c  

^a Kyung Hee University Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Glucose tolerance; Insulin sensitivity; Irisin; Skeletal muscle; Visceral fat

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRISIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN; LIPID;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION ANALYZER; BODY MASS; BONE MASS; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPOTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; SKELETAL MUSCLE MASS TO VISCERAL FAT AREA RATIO; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; IMPEDANCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDIABETIC STATE; SKELETAL MUSCLE; SOUTH KOREA; YOUNG ADULT;

ADIPOSITY; ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ELECTRIC IMPEDANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLE, SKELETAL; PHENOTYPE; PREDIABETIC STATE; REPUBLIC OF KOREA; RISK FACTORS; YOUNG ADULT;

EID: 84955273417     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-015-0319-8     Document Type: Article

References (22)

1. Yoo HJ, Choi KM. Hepatokines as a link between Obesity and Cardiovascular diseases. Diabetes Metab J. 2015;39:10-5.
2. Hwang YC, Jeong IK, Ahn KJ, Chung HY. Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int. 2012;23:1337-42.
3. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-8.
4. Munoz-Canoves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 2013;280:4131-8.
5. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457-65.
6. Gamas L, Matafome P, Seiça R. Irisin and myonectin regulation in the insulin resistant muscle: implications to adipose tissue: muscle crosstalk. J Diabetes Res. 2015;2015:359159.
7. Timmons JA, Baar K, Davidsen PK, Atherton PJ. Is irisin a human exercise gene? Nature. 2012;488:E9-10 (discussion E10-E11).
8. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013;100:96-101.
9. Duran ID, Gülçelik NE, Ünal M, Topçuoglu C, Sezer S, Tuna MM, Berker D, Güler S. Irisin levels in the progression of diabetes in sedentary women. Clin Biochem. 2015; doi: 10.1016/j.clinbiochem.2015.07.098.
10. Ebert T, Kralisch S, Wurst U, Scholz M, Stumvoll M, Kovacs P, Fasshauer M, Tönjes A. Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations. Int J Obes (Lond). 2015; doi: 10.1038/ijo.2015.157.
11. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, Tsoukas M, Geladari EV, Young Huh J, Dincer F, Davis CR, Crowell JA, Mantzoros CS. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899-907.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
13. Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA. 2001;285:2486-97.
15. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernandez-Real JM. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769-78.
16. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725-38.
17. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, Kim KW, Lim JY, Park KS, Jang HC. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean longitudinal study on health and aging (KLoSHA). Diabetes Care. 2010;33:1652-4.
18. Park BS, Yoon JS. Relative skeletal muscle mass is associated with development of metabolic syndrome. Diabetes Metab J. 2013;37:458-64.
19. Kim TN, Park MS, Lim KI, Yang SJ, Yoo HJ, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi SD, Choi KM. Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Res Clin Pract. 2011;93:285-91.
20. Ogawa H, Fujitani K, Tsujinaka T, Imanishi K, Shirakata H, Kantani A, Hirao M, Kurokawa Y, Utsumi S. InBody 720 as a new method of evaluating visceral obesity. Hepatogastroenterology. 2011;58:42-4.
21. Albrecht E, Norheim F, Thiede B, Holen T, Ohashi T, Schering L, Lee S, Brenmoehl J, Thomas S, Drevon CA, Erickson HP, Maak S. Irisin-a myth rather than an exercise-inducible myokine. Sci Rep. 2015;5:8889.
22. Choi HY, Kim S, Park JW, Lee NS, Hwang SY, Huh JY, Hong HC, Yoo HJ, Baik SH, Youn BS, Mantzoros CS, Choi KM. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. J Clin Endocrinol Metab. 2014;99:2778-85.